Testing a Modified Family Planning Intervention for Postpartum Women in Uganda

Contraceptive Usage Clinical Trial

Official title:

Modification of an Evidence-based Family Planning Intervention for a New Target Population: Postpartum Women in Nakaseke District, Uganda - Pilot Phase, Two Arm

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04068870
• Other study ID #: UGPPFP
• Status: Recruiting
• Phase: Phase 1
• Start date: August 5, 2019
• Est. completion date: April 2020

Study information

• Verified date: August 2019
• Source: University of Vermont
• Contact: Sarah Heil, PhD
• Phone: 802-656-8712
• Email: sarah.heil[@]uvm.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to test whether offering incentives to encourage women to attend one-on-one family planning education sessions and offering free, onsite prescription contraceptive methods increases use and continuation of prescription contraception among postpartum women in Uganda. This intervention is modified from one that has been effective outside of Uganda.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: April 2020
• Est. primary completion date: April 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• 18-45 years of age

• Not planning on getting pregnant in the next 4 months

• Less than 3 months postpartum

• No history of tubal ligation or hysterectomy

• No recent prescription contraceptive use (no pill, intrauterine device or implant use in the past 7 days or injection use in the past 3 months)

• Medically eligible to use prescription contraceptives

• Bringing baby to immunization clinic for the first time

Exclusion Criteria:

• Failure to meet the aforementioned inclusion criteria

Related Conditions & MeSH terms

• Contraceptive Usage

Intervention

Behavioral:
• Contraceptive management program
The contraceptive management program will consist of two components: (1) the World Health Organization's contraception protocol and (2) incentivized visits.

Locations

Country	Name	City	State
Uganda	Nakaseke District Hospital	Nakaseke

Sponsors (2)

Lead Sponsor	Collaborator
University of Vermont	African Community Center for Social Sustainability

Country where clinical trial is conducted

Uganda, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Period prevalence use of a prescription contraceptive	Period prevalence use of a prescription contraceptive	6 months after delivery